<?xml version="1.0" encoding="UTF-8"?>
<ref id="b21-ijmm-46-02-0489">
 <label>21</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meyer</surname>
    <given-names>NJ</given-names>
   </name>
   <name>
    <surname>Reilly</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>BJ</given-names>
   </name>
   <name>
    <surname>Palakshappa</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Jones</surname>
    <given-names>TK</given-names>
   </name>
   <name>
    <surname>Dunn</surname>
    <given-names>TG</given-names>
   </name>
   <name>
    <surname>Shashaty</surname>
    <given-names>MGS</given-names>
   </name>
   <name>
    <surname>Feng</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Christie</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Opal</surname>
    <given-names>SM</given-names>
   </name>
  </person-group>
  <article-title>Mortality benefit of recombinant human interleukin-1 receptor antagonist for sepsis varies by initial interleukin-1 receptor antagonist plasma concentration</article-title>
  <source>Crit Care Med</source>
  <volume>46</volume>
  <fpage>21</fpage>
  <lpage>28</lpage>
  <year>2018</year>
  <pub-id pub-id-type="doi">10.1097/CCM.0000000000002749</pub-id>
  <pub-id pub-id-type="pmid">28991823</pub-id>
 </element-citation>
</ref>
